Motalib Smahi
Eaubonne, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
APTT therapeutic range for monitoring unfractionated heparin therapy. Significant impact of the anti-Xa reagent used for correlation: Response from original authors Toulon et al.
Journal: Journal of thrombosis and haemostasis : JTH
Published: April 20, 2021
APTT therapeutic range for monitoring unfractionated heparin therapy. Significant impact of the anti-Xa reagent used for correlation.
Journal: Journal of thrombosis and haemostasis : JTH
Published: November 12, 2020
Age-adjusted D-dimer cut-off levels to rule out venous thromboembolism in patients with non-high pre-test probability: Clinical performance and cost-effectiveness analysis.
Journal: Journal of thrombosis and haemostasis : JTH
Published: October 05, 2020
Monitoring unfractionated heparin therapy: Lack of standardization of anti-Xa activity reagents.
Journal: Journal of thrombosis and haemostasis : JTH
Published: April 14, 2020
Factor VIII and IX assays for post-infusion monitoring in hemophilia patients: Guidelines from the French BIMHO group (GFHT).
Journal: European journal of haematology
Published: January 12, 2020
Factor IX assays in treated hemophilia B patients
Journal: Annales de biologie clinique
Published: February 26, 2019
Factor VIII assays in treated hemophilia A patients
Journal: Annales de biologie clinique
Published: February 26, 2019
In vitro sensitivity of different activated partial thromboplastin time reagents to mild clotting factor deficiencies.
Journal: International journal of laboratory hematology
Published: September 21, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026